, Singapore

Daily Markets Briefing: STI down 0.4%

Index likely to consolidate around current levels.

IG Markets Singapore said:

In Singapore, the STI suffered from a lower-than-expected rise in ADP private sector jobs and slid 0.4% yesterday. We expect Singapore to trade off the Nikkei rally as Hong Kong and Taiwan is on holiday.

OCBC Investment Research noted:

As a recap, the STI pull backed about 0.4% yesterday as investors remain hesitant about pushing the index beyond the 3320-3330 resistance zone.

And with today’s tone likely to turn fairly neutral ahead of the weekend break, we could see the index consolidating around current levels with the immediate support pegged at the 3300 minor trough.

Below that, the next support is pegged at the 3280 minor resistance-turned-support. On the upside, the immediate resistance is now marked at the 3330 minor peak, followed by the subsequent resistance at the 3400 psychological hurdle. 

Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

The people you want to reach are already in this room.

Every quarter, SBR lands on the desks of the founders, CFOs, and directors running Asia's most consequential companies. Every day, they open our newsletter and read our website. It's a room that took twenty years to build — and it's the one most of our partners are trying to get into.

The good news is that the door is open. We work with companies on thought leadership articles, sponsored content, industry summits across Southeast Asia, regional awards programmes, podcasts, and media placements in print and digital. The shape of the right partnership depends on what you're trying to do, which is why we'd rather start with a conversation than send a rate card.


If you have something this room should know about, tell us. We'll tell you honestly whether we can help, and how.

No rate cards until we understand the brief. It's a better use of everyone's time.

Top News

AI growth stalls as 78% cite weak data infrastructure
Confluent said firms are prioritising data streaming as they move AI projects from pilots into production.
Singapore emerges as key hub in Asia-Pacific’s next medtech wave
The city-state’s regulatory strength helps translate medical innovations into globally validated products.
Healthcare